###begin article-title 0
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 43 45 43 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 49 54 <span type="species:ncbi:10090">Mouse</span>
Conditional Inactivation of Brca1, p53 and Rb in Mouse Ovaries Results in the Development of Leiomyosarcomas
###end article-title 0
###begin p 1
###xml 40 43 <span type="species:ncbi:11128?0.8931297709923665">BCV</span>
###xml 109 112 <span type="species:ncbi:11128?0.8931297709923665">BCV</span>
###xml 188 191 <span type="species:ncbi:11128?0.8931297709923665">BCV</span>
Conceived and designed the experiments: BCV. Performed the experiments: KVCK OC. Analyzed the data: KVCK MKS BCV. Contributed reagents/materials/analysis tools: MKS. Wrote the paper: KVCK BCV.
###end p 1
###begin p 2
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 692 697 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 699 702 699 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 707 709 707 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 813 816 813 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 928 933 928 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 938 941 938 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 951 953 951 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 958 961 958 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1074 1079 1074 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1224 1227 1224 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1235 1237 1235 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1239 1244 1239 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1391 1394 1391 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1402 1404 1402 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1434 1439 1434 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 496 502 <span type="species:ncbi:10090">murine</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 890 894 <span type="species:ncbi:10090">mice</span>
###xml 1116 1122 <span type="species:ncbi:10090">murine</span>
###xml 1678 1682 <span type="species:ncbi:10090">mice</span>
Epithelial ovarian cancer (EOC) is thought to arise in part from the ovarian surface epithelium (OSE); however, the molecular events underlying this transformation are poorly understood. Germline mutations in the BRCA1 tumor suppressor gene result in a significantly increased risk of developing EOC and a large proportion of sporadic EOCs display some sort of BRCA1 dysfunction. To generate a model in which Brca1-mediated transformation can be studied, we previously inactivated Brca1 alone in murine OSE, which resulted in an increased accumulation of premalignant changes, but no tumor formation. In this study, we examined tumor formation in mice with conditionally expressed alleles of Brca1, p53 and Rb, alone or in combination. Intrabursal injection of adenovirus expressing Cre recombinase to inactivate p53 resulted in tumors in 100% of mice. Tumor progression was accelerated in mice with concomitant inactivation of Brca1 and p53, but not Rb and p53. Immunohistologic analyses classified the tumors as leiomyosarcomas that may be arising from the ovarian bursa. Brca1 inactivation in primary cultures of murine OSE cells led to a suppression of proliferation that could be rescued by concomitant inactivation of p53 and/or Rb. Brca1-deficient OSE cells displayed an increased sensitivity to the DNA damaging agent cisplatin, and this effect could be modulated by inactivation of p53 and/or Rb. These results indicate that Brca1 deficiency can accelerate tumor development and alter the sensitivity of OSE cells to chemotherapeutic agents. Intrabursal delivery of adenovirus intended to alter gene expression in the ovarian surface epithelium may, in some strains of mice, result in more rapid transformation of adjacent cells, resulting in leiomyosarcomas.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 94 97 94 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Auersperg1">[1]</xref>
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Hirst1">[2]</xref>
###xml 221 224 221 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Roh1">[5]</xref>
###xml 439 442 439 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Auersperg2">[6]</xref>
###xml 818 821 818 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Sundfeldt1">[7]</xref>
###xml 832 835 832 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Auersperg1">[1]</xref>
###xml 1100 1105 1100 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1229 1232 1229 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Salazar1">[8]</xref>
###xml 1233 1237 1233 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Werness1">[10]</xref>
###xml 1297 1302 1297 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1373 1377 1373 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Finch1">[11]</xref>
###xml 962 967 <span type="species:ncbi:9606">women</span>
Epithelial ovarian cancer (EOC) is thought to arise from the ovarian surface epithelium (OSE) [1], although recent evidence implicates the fallopian tube as a potential tissue of origin of EOC of the serous histotype [2]-[5]. Embryonically derived from the coelemic epithelium, the OSE is a single layer of squamous to cuboidal cells that demonstrates a plastic phenotype reflecting its ability to undergo epithelio-mesenchymal transition [6]. With age and repeated ovulatory cycles, the OSE assumes a more irregular contour and forms invaginations or clefts into the stroma, which may pinch off completely and form epithelial inclusion cysts within the ovary. These crypts and cysts often show evidence of early metaplastic changes in cell shape and express markers up-regulated in ovarian tumors, such as E-cadherin [7] and CA125 [1], which suggests that these premalignant lesions may give rise to ovarian neoplasias. Prophylactic oophorectomy specimens from women at high risk for developing ovarian cancer, due to a strong family history of the disease or the presence of a germline mutation in BRCA1, have more of these morphological changes in the OSE than ovaries removed incidentally during total abdominal hysterectomy [8]-[10]. In one study, 6% of prophylactically removed ovaries from BRCA1 mutation carriers were found to harbor microscopic ovarian carcinomas [11].
###end p 4
###begin p 5
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Berchuck1">[12]</xref>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Pal1">[13]</xref>
###xml 313 317 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Aunoble1">[14]</xref>
###xml 319 323 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-King1">[15]</xref>
###xml 355 360 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 572 576 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Geisler1">[16]</xref>
###xml 577 581 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Chan1">[18]</xref>
###xml 587 592 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 701 705 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Yu1">[19]</xref>
###xml 741 745 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Chen1">[20]</xref>
###xml 747 751 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Yoshida1">[21]</xref>
###xml 783 787 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Larson1">[22]</xref>
###xml 789 793 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Yan1">[23]</xref>
###xml 809 813 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Shao1">[24]</xref>
Five to fifteen percent of ovarian cancers are thought to be due to hereditary factors and the majority of these can be attributed to germline mutations in the BRCA1 gene [12], [13]. These germline mutations confer a lifetime risk of ovarian cancer up to 60% compared to approximately2% in the general population [14], [15]. Although somatic mutations in BRCA1 are rare, reduced or absent protein expression has been observed in up to 90% of sporadic ovarian tumors indicating that epigenetic factors, mainly promoter hypermethylation, are also involved in its regulation [16]-[18]. The BRCA1 gene has been implicated in a wide variety of cellular processes, including maintenance of genome integrity [19], DNA damage recognition and repair [20], [21], cell cycle checkpoint control [22], [23], and apoptosis [24].
###end p 5
###begin p 6
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Ramus1">[25]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Zweemer1">[26]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Cressman1">[27]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Liu1">[29]</xref>
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Cressman2">[30]</xref>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Xu1">[31]</xref>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Xu1">[31]</xref>
###xml 122 127 <span type="species:ncbi:10090">Mouse</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
Up to 60% of BRCA1 mutation-associated ovarian tumors also display mutations in the p53 tumor suppressor gene [25], [26]. Mouse models of mammary tumorigenesis have revealed a role for p53 in Brca1-related transformation [27]-[29]. In mice in which Brca1 was inactivated in the mammary epithelium, the latency of tumor formation could be shortened by the concomitant inactivation of the p53 tumor suppressor gene [30], [31]. Downregulaton of BRCA1 results in increased p53 and p21 expression [31], which may represent a significant obstacle to tumorigenesis that can be overcome by somatic mutation of the p53 gene.
###end p 6
###begin p 7
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Aprelikova1">[32]</xref>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 279 282 279 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2F</italic>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 329 336 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2F1</italic>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Wang1">[33]</xref>
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 412 414 412 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RB</italic>
###xml 423 425 423 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RB</italic>
###xml 441 445 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p107</italic>
###xml 450 454 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p130</italic>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Fan1">[34]</xref>
###xml 501 503 501 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RB</italic>
###xml 508 513 508 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
The ability of BRCA1 to suppress cellular proliferation may depend, at least in part, on its association with the retinoblastoma tumor suppressor (RB), since RB preferentially binds to exon 11 of BRCA1[32]. RB has also been shown to modify BRCA1 expression via its modulation of E2F transcriptional activity, with BRCA1 being an in vivo target of E2F1[33]. And overexpression of BRCA1 inhibits the expression of RB and the RB family members p107 and p130[34]. No association has yet been made between RB and BRCA1 dysfunction in ovarian cancer.
###end p 7
###begin p 8
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 11 13 11 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 182 185 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 190 192 190 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-FleskenNikitin1">[35]</xref>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 592 595 592 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 709 719 709 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1, p53</italic>
###xml 725 727 725 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
###xml 200 205 <span type="species:ncbi:10090">mouse</span>
###xml 295 301 <span type="species:ncbi:10090">murine</span>
###xml 481 487 <span type="species:ncbi:10090">murine</span>
###xml 792 797 <span type="species:ncbi:10090">mouse</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
###xml 1022 1027 <span type="species:ncbi:9606">human</span>
###xml 1106 1110 <span type="species:ncbi:10090">mice</span>
The Brca1, Rb and p53 tumor suppressors have been conditionally inactivated in mouse OSE to study their roles in ovarian epithelial cell transformation. Simultaneous inactivation of p53 and Rb in the mouse OSE led to the development of malignant ovarian tumors [35]. We inactivated Brca1 in the murine OSE which resulted in the increased accumulation of premalignant changes, although no tumor formation was observed after one year [36]. However, inactivation of Brca1 in cultured murine OSE (MOSE) cells resulted in a slowed proliferation that could be rescued by concurrent inactivation of p53[36]. In the present study, a conditional and site-directed strategy was employed to test whether inactivation of Brca1, p53, and Rb in various combinations in the OSE is sufficient to establish a mouse model of Brca1-associated ovarian cancer. The ovaries of these mice were examined at various time points to determine if there were progressive alterations in epithelial morphology or tumor formation as has been observed in human prophylactic oophorectomy specimens. Primary cultures of OSE cells from these mice were also established to determine the impact of combined inactivation of these genes on their rate of proliferation and sensitivity to cisplatin.
###end p 8
###begin title 9
Materials and Methods
###end title 9
###begin title 10
Experimental Animals
###end title 10
###begin p 11
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 5 14 5 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 29 35 29 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Brn</sup>
###xml 24 35 24 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>tm2Brn</sup></italic>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 129 139 129 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> loxP/loxP</sup>
###xml 154 160 154 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Brn</sup>
###xml 149 160 149 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trp53<sup>tm1Brn</sup></italic>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Jonkers1">[37]</xref>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 353 362 353 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 375 378 375 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb1</italic>
###xml 378 384 378 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Brn</sup>
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Vooijs1">[38]</xref>
###xml 435 437 435 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 622 627 622 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 627 636 627 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 637 640 637 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 640 650 640 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> loxP/loxP</sup>
###xml 654 655 654 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sup>
###xml 652 655 652 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>l</sup></italic>
###xml 655 663 655 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oxP/loxP</sup>
###xml 664 667 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 667 676 667 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 682 684 682 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 684 693 684 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 694 699 694 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 699 708 699 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 827 832 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 832 841 832 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 842 844 842 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 844 853 844 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 854 857 854 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 857 866 857 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 980 1022 980 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Guidelines for the Care and Use of Animals</italic>
###xml 1211 1218 1211 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1269 1273 1269 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 244 249 <span type="species:ncbi:10090">Mouse</span>
###xml 260 265 <span type="species:ncbi:9606">Human</span>
###xml 285 290 <span type="species:ncbi:10090">Mouse</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
Brca1loxP/loxP [FVB;129-Brca1tm2Brn] conditional knockout mice, bearing loxP sites in introns 4 and 13 of the Brca1 gene, and p53 loxP/loxP [FVB;129-Trp53tm1Brn] [37] mice bearing loxP in introns 1 and 10 of the p53 gene were obtained from the Mouse Models of Human Cancers Consortium Mouse Repository (National Cancer Institute, Rockville, MD, USA). RbloxP/loxP mice [129sv-Rb1tm2Brn] [38], bearing loxP sites flanking exon 19 of the Rb gene, were obtained from Dr. Ruth Slack at the University of Ottawa (Ottawa, Ontario, Canada). The mice were intercrossed through multiple generations to create colonies of homozygous Brca1loxP/loxP/p53 loxP/loxP, RbloxP/loxP/p53loxP/loxP, and RbloxP/loxP/Brca1loxP/loxP double conditional knockout mice. These mice were then intercrossed through successive generations in order to obtain Brca1loxP/loxP/RbloxP/loxP/p53loxP/loxP triple conditional knockout mice. All animal experiments described in this study were performed according to the Guidelines for the Care and Use of Animals established by the Canadian Council on Animal Care. Recombinant adenoviruses Ad5CMVeGFP (AdGFP) or Ad5CMVCre (AdCre) (Vector Development Laboratory, Houston, TX) were delivered to the OSE in vivo via intrabursal injection as previously described [36].
###end p 11
###begin title 12
Genotyping and Detection of Recombination
###end title 12
###begin p 13
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 96 105 96 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Sgagias1">[39]</xref>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 159 168 159 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 215 248 215 248 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CAC AAA AAC AGG TTA AAC CAG 3&#8242;</named-content>
###xml 266 298 266 298 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; AGC ACA TAG GAG GCA GAG AC 3&#8242;</named-content>
###xml 399 431 399 431 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; AAG GGG TAT GAG GGA CAA GG 3&#8242;</named-content>
###xml 450 482 450 482 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GAA GAC AGA AAA GGG GAG GG 3&#8242;</named-content>
###xml 632 635 632 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 658 661 658 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 661 670 661 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 922 924 918 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 924 933 920 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 974 1002 970 998 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GGC GTG TGC CAT CAA TG 3&#8242;</named-content>
###xml 1014 1042 1010 1038 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; AAC TCA AGG GAG ACC TG 3&#8242;</named-content>
###xml 1217 1219 1213 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1247 1249 1243 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1249 1256 1245 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 1283 1320 1275 1312 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GAA AGG AAA GTC AGG GAC ATT GGG 3&#8242;</named-content>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 934 938 <span type="species:ncbi:10090">mice</span>
###xml 1064 1068 <span type="species:ncbi:10090">mice</span>
###xml 1105 1109 <span type="species:ncbi:10090">mice</span>
Genomic DNA was extracted from ear punches or cultured cells as previously described [36]. Brca1loxP/loxP mice were genotyped as previously described [39]. p53loxP/loxP mice were genotyped using primers p53int1fwd (5' CAC AAA AAC AGG TTA AAC CAG 3') and p53int1rev (5' AGC ACA TAG GAG GCA GAG AC 3') to yield a 288 bp band for wild-type or a 370 bp band for floxed sequences or primers p53int10fwd (5' AAG GGG TAT GAG GGA CAA GG 3') and p53int10rev (5' GAA GAC AGA AAA GGG GAG GG 3'), which yield a 431 bp or a 584 bp fragment for wild-type and floxed sequences respectively. For detection of Cre-mediated excision of exons 2-10 of p53 (hereafter designated p53Delta2-10), primers p53int1fwd and p53int10rev were used, yielding a 612 bp product. Remaining unrecombined sequence following Cre exposure was detected using primers p53int1fwd and p53int1rev or primers p53int10fwd and p53int10rev in a separate amplification. RbloxP/loxP mice were genotyped using primers Rb18 (5' GGC GTG TGC CAT CAA TG 3') and Rb19 (5' AAC TCA AGG GAG ACC TG 3'). DNA from wild-type mice yielded a 750 bp band, while floxed mice were identified by the presence of a 650 bp band. For detection of Cre-mediated excision of exon 19 of the Rb gene (hereafter designated RbDelta19), primers Rb18 and Rb212 (5' GAA AGG AAA GTC AGG GAC ATT GGG 3') were used, yielding a 260 bp product when recombination has occurred and a 750 bp product for the unrecombined fraction.
###end p 13
###begin title 14
Tissue Collection
###end title 14
###begin p 15
###xml 29 30 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 724 728 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 730 734 <span type="species:ncbi:10090">Mice</span>
###xml 989 993 <span type="species:ncbi:10090">mice</span>
Animals were euthanized by CO2 asphyxiation at 60, 120, 180, or 240 days post-injection of AdGFP or AdCre. The ovaries (with the ovarian fat pad and bursa intact) were removed individually along with the attached oviduct and a portion of the uterus, fixed in formalin and paraffin-embedded. Five microm serial sections were cut for H&E staining and morphological changes to the OSE were assessed by examining five non-consecutive sections of each ovary at 200x magnification using an Olympus BX50 microscope (Olympus, Melville, NY, USA). Samples were blinded prior to examination. Sections were evaluated for the number of areas of columnar cells, areas of hyperplasia, and invaginations of the OSE, as described previously [36]. Mice that developed tumors were euthanized when they had reached a loss-of-wellness endpoint due to tumor burden, defined as any or all of the following: presence of respiratory distress, rapid weight loss or gain >5 g from the average body weight of control mice of the same age, and presence of a palpable mass or abdominal distention that impairs mobility. Tumors were removed, fixed in formalin and paraffin embedded, with a small piece of tissue reserved for genomic DNA isolation. Serial sections of tumor tissue with a thickness of 5 microm were cut for H&E staining and immunohistochemistry.
###end p 15
###begin title 16
Immunohistochemistry
###end title 16
###begin p 17
###xml 1364 1365 1353 1354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1366 1367 1355 1356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 469 472 <span type="species:ncbi:10116">rat</span>
###xml 564 567 <span type="species:ncbi:10116">rat</span>
###xml 592 597 <span type="species:ncbi:10090">mouse</span>
###xml 644 649 <span type="species:ncbi:10090">mouse</span>
###xml 681 684 <span type="species:ncbi:10116">rat</span>
###xml 747 750 <span type="species:ncbi:10116">rat</span>
###xml 918 924 <span type="species:ncbi:9986">rabbit</span>
###xml 1035 1046 <span type="species:ncbi:3704">horseradish</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
###xml 1138 1143 <span type="species:ncbi:10090">Mouse</span>
Paraffin sections were deparaffinized in xylene and rehydrated in ethanol according to standard protocol. High temperature antigen retrieval was performed using sodium citrate buffer (pH 6.0) and endogenous peroxidase activity was blocked using 3% hydrogen peroxide in Stockholm PBS (S-PBS). All samples were blocked using an avidin/biotin blocking kit (DAKO, Cytomation, Carpentaria, CA, USA). Primary antibodies were diluted in S-PBS at the following concentrations: rat anti-CK19, 1:100 (TROMA-1, Developmental Studies Hybridoma Bank, University of Iowa, USA); rat anti-Ki67, 1:25 (DAKO); mouse-anti smooth muscle actin (SMA), 1:100 (DAKO); mouse anti-Desmin, 1:100 (DAKO); and rat anti-CD34, 1:50 (Novus Biologicals). For antibodies raised in rat, sections were incubated with primary antibody at room temperature for 2 hours or overnight. Following three 5 min washes in S-PBS, sections were stained with an anti-rabbit secondary antibody (1:200, DAKO) for 20 min followed by three 5 min washes and incubation with a streptavidin/horseradish peroxidase solution (1:200, DAKO) for 20 min. For antibodies raised in mice, the Vector(R) Mouse on Mousetrade mark immunodetection kit (Vector Laboratories, Burlingame, CA, USA) was used according to manufacturer specifications. Developing was performed with diaminobenzidine (DAB) as a substrate (0.2% DAB, 0.001% H2O2; Sigma-Aldrich). Slides were counterstained with hematoxylin, dehydrated, and coverslipped with Permount mounting medium (Fisher Scientific, Ottawa, ON, Canada).
###end p 17
###begin title 18
MOSE Proliferation and Sensitivity to Cisplatin
###end title 18
###begin p 19
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 124 125 124 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-FleskenNikitin1">[35]</xref>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
Primary cultures of MOSE cells were established and maintained as previously described [36]. For in vitro infections, 5.0x105 MOSE cells of the various genotypes were infected with either AdCre or AdGFP following an established protocol [35], and experiments to evaluate proliferation and cisplatin sensitivity were performed following cell replating 72 hours later, as described previously [36]. Proliferation of MOSE cells was also assessed several passages (4-9) after infection. Experiments were performed three times in triplicate, with a separate infection for each replicate.
###end p 19
###begin title 20
Statistical Analyses
###end title 20
###begin p 21
###xml 173 174 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Cell counts are expressed as the mean+/-SEM of three independent experiments performed in triplicate. The probability of significant differences was determined by Student's t test (two groups) and by analysis of variance (ANOVA; multiple groups). Bonferroni's post-test was used to determine significance between specific treatments when whole group differences were detected by ANOVA. Survival curves were compared using a Log-Rank test. For all analyses, significance was inferred at P<0.05 and P values were two-sided. Analyses were performed using Graphpad Prism statistical software (Graphpad Software, San Diego, CA, USA).
###end p 21
###begin title 22
Results
###end title 22
###begin title 23
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 65 67 65 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
Conditional Inactivation of Brca1 in Conjunction with p53 and/or Rb Using Intrabursal Injection
###end title 23
###begin p 24
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 252 254 252 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 468 470 468 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 470 477 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 499 501 495 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 501 510 497 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 552 559 548 555 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 552 559 548 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008534-t001"><bold>Table 1</bold></xref>
###xml 674 679 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 679 688 675 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 796 798 788 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 798 805 790 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 968 970 952 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 970 979 954 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
We have previously shown that inactivation of Brca1 alone in the OSE resulted in an increase in the number of preneoplastic changes in the OSE after 240 days, but no tumor formation [36]. In this study we observed that no tumors arose in mice in which Rb alone was conditionally inactivated, even after one year following intrabursal injection of AdCre. There were no significant differences in the number of morphological changes in the OSE between the AdCre-treated RbDelta19 mice and the control RbloxP/loxP mice at any of the time points examined (Table 1). There was no significant age-related increase in the total number of changes, as was previously observed in the Brca1Delta5-13 mice. However, the mean number of morphological changes in the OSE doubled between 120 and 180 days in the RbDelta19 mice (4.32+/-0.78 versus 8.52+/-0.80 mean changes per section over five non-consecutive sections per ovary, P<0.05), whereas this difference was not noted in the RbloxP/loxP mice.
###end p 24
###begin title 25
###xml 98 100 98 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
Distribution of morphological features in the OSE over time following conditional inactivation of Rb.
###end title 25
###begin p 26
Numbers represent the mean+/-SEM number of morphological changes per section over five non-consecutive sections in n ovaries. Superscript letters denote a significant difference between time points for that treatment group.
###end p 26
###begin p 27
###xml 60 62 60 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 281 283 281 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 283 290 283 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 291 296 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 296 305 292 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 322 324 314 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 324 333 316 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 334 339 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 339 348 331 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 385 392 377 384 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 385 392 377 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008534-t002"><bold>Table 2</bold></xref>
###xml 500 502 492 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 502 509 494 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 510 515 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 515 524 503 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 598 599 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sup>
###xml 596 599 576 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>l</sup></italic>
###xml 599 607 579 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oxP/loxP</sup>
###xml 608 613 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 613 622 593 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 697 699 677 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 699 706 679 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 707 712 683 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 712 721 688 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
Tumor formation was also not observed in mice in which both Rb and Brca1 were concomitantly inactivated via intrabursal injection of AdCre. The number of morphological changes in the OSE increased over time in both groups, however there were no significant differences between the RbDelta19/Brca1Delta5-13 ovaries and the RbloxP/loxP/Brca1loxP/loxP ovaries at any time point examined (Table 2). There was a significant increase in the number of areas of columnar cells between 60 and 240 days in the RbDelta19/Brca1Delta5-13 mice (1.96+/-0.45 versus 5.18+/-0.70, P<0.01) that was not seen in the RbloxP/loxP/Brca1loxP/loxP mice. As well, epithelial invaginations were noted only in the OSE of the RbDelta19/Brca1Delta5-13 mice.
###end p 27
###begin title 28
###xml 98 100 98 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
Distribution of morphological features in the OSE over time following conditional inactivation of Rb and Brca1.
###end title 28
###begin p 29
Numbers represent the mean+/-SEM of the number of morphological changes per section over five non-consecutive sections in n ovaries. Letters are used to denote a significant difference between time points for that treatment group.
###end p 29
###begin p 30
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 121 130 121 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 132 134 128 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 134 141 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 142 145 134 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 145 154 137 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 156 161 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 161 170 149 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 171 174 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 174 183 158 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 189 191 169 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 191 198 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 199 202 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 202 211 178 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 212 217 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 217 226 189 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 228 235 196 203 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 228 235 196 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008534-t003"><bold>Table 3</bold></xref>
###xml 638 646 606 614 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 638 646 606 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g001"><bold>Figure 1</bold></xref>
###xml 1015 1017 983 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1017 1024 985 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 1025 1028 989 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1028 1037 992 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 1038 1043 998 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1043 1052 1003 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 1205 1212 1161 1168 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 1205 1212 1161 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008534-t003"><bold>Table 3</bold></xref>
###xml 1262 1270 1218 1226 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 1262 1270 1218 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g002"><bold>Figure 2</bold></xref>
###xml 1320 1323 1276 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1366 1371 1322 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 1053 1057 <span type="species:ncbi:10090">mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
Tumor formation was observed following intrabursal injection of AdCre to generate cells with the following genotypes: p53Delta2-10, RbDelta19/p53Delta2-10, Brca1Delta5-13/p53Delta2-10, and RbDelta19/p53Delta2-10/Brca1Delta5-13 (Table 3). No tumors were observed in any of the mice injected with adenoviral GFP when followed to one year post-intrabursal injection. The presentation of the mice at endpoint was similar in all of the groups examined, with either a large, palpable dorsal mass(es) or severe abdominal distention. The period between onset of symptoms and loss-of-wellness endpoint was quite short, generally one week or less. Figure 1 illustrates the general appearance of the tumors upon necropsy for each genotype. The tumors were most often located at the end of the uterine horn involving the ovary and sometimes engulfing surrounding organs such as the pancreas and the spleen. Both ovaries were subjected to intrabursal injection in all animals, however bilateral tumors were only observed in the RbDelta19/p53Delta2-10/Brca1Delta5-13 mice, and only in 2 of 14 animals. The incidence, median survival, range of survival and presence of ascites for these groups of mice are summarized in Table 3 with the Kaplan-Meier survival plots depicted in Figure 2. When compiled, these data indicate that loss of p53 is necessary for tumor formation and that Brca1 deficiency accelerates tumor initiation and/or progression.
###end p 30
###begin title 31
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Gross tumor presentation of mice at loss-of-wellness endpoint following intrabursal administration of AdCre.
###end title 31
###begin p 32
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 64 67 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 76 78 76 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 115 124 115 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 126 127 122 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 130 135 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 135 144 131 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 145 148 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 148 157 140 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 159 160 147 148 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 163 165 151 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 165 172 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 173 176 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 176 185 160 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 187 188 167 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 195 197 175 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 197 204 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 205 208 181 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 208 217 184 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 218 223 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 223 232 195 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 234 235 202 203 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Representative images of tumors arising in mice in which Brca1, p53, and/or Rb had been inactivated in the OSE: p53Delta2-10 (A), Brca1Delta5-13/p53Delta2-10 (B), RbDelta19/p53Delta2-10 (C), and RbDelta19/p53Delta2-10/Brca1Delta5-13 (D).
###end p 32
###begin title 33
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
Survival of mice following inactivation of multiple tumor suppressors in the OSE in vivo.
###end title 33
###begin p 34
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 105 107 105 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 141 142 141 142 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 181 190 181 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 191 194 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 194 203 190 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 264 267 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 267 276 259 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 304 305 292 293 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 339 344 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 344 353 332 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 354 357 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 357 366 341 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 424 426 404 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 426 433 406 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 434 437 410 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 437 446 413 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 473 474 445 446 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 508 510 480 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 510 517 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 518 521 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 521 530 489 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 531 536 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 536 545 500 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 603 605 563 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 605 612 565 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 613 616 569 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 616 625 572 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 651 652 603 604 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 686 688 638 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 688 695 640 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 696 699 644 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 699 708 647 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 709 714 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 714 723 658 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 767 772 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 772 781 712 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 782 785 718 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 785 794 721 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 724 728 <span type="species:ncbi:10090">mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
Kaplan-Meier plots showing the time to loss-of-wellness endpoint of the mice in which Brca1, p53, and/or Rb had been inactivated in the OSE. A) The median survival time of the Brca1Delta5-13/p53Delta2-10 mice (147.5 days) is significantly shorter than that of the p53Delta2-10 mice (179.5 days), P<0.05. B) The median survival time of the Brca1Delta5-13/p53Delta2-10 mice (147.5 days) is significantly less than that of the RbDelta19/p53Delta2-10 mice (170 days), P<0.001. C) The median survival time of the RbDelta19/p53Delta2-10/Brca1Delta5-13 mice (118.5 days) is significantly less than that of the RbDelta19/p53Delta2-10 mice (170 days), P<0.05. D) The median survival time of the RbDelta19/p53Delta2-10/Brca1Delta5-13 mice (118.5 days) is less than that of the Brca1Delta5-13/p53Delta2-10 mice (147.5 days), although the difference in survival was not statistically significant.
###end p 34
###begin title 35
Tumor formation following intrabursal injection of adenoviral Cre recombinase.
###end title 35
###begin p 36
###xml 10 14 <span type="species:ncbi:10090">mice</span>
Number of mice indicates the number of animals who received intrabursal injection of adenoviral Cre recombinase and were euthanized when they had reached a loss-of-wellness endpoint due to tumor burden or had reached the 240 day time point.
###end p 36
###begin p 37
###xml 98 106 98 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3</bold>
###xml 98 106 98 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g003"><bold>Figure 3</bold></xref>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
Recombination at the relevant loxP sites was confirmed in genomic DNA from all the tumor samples (Figure 3). Unrecombined DNA was also detectable in all tumor samples, which was not unexpected given that the tumors are likely composed of both tumor cells and the cells of the normal tissue they have invaded. Recombination at the relevant loxP sites was also detectable in genomic DNA from ascites cells isolated from tumor-bearing mice (data not shown).
###end p 37
###begin title 38
Recombination at loxP sites in the relevant tumor suppressor genes in tumor samples.
###end title 38
###begin p 39
###xml 207 212 <span type="species:ncbi:10090">mouse</span>
PCR of genomic DNA extracted from the tumor and the corresponding tail (control for lack of recombination) to detect recombination at loxP sites of the tumor suppressor genes relevant to the genotype of the mouse.
###end p 39
###begin title 40
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 91 93 91 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 38 42 <span type="species:ncbi:10090">Mice</span>
Histopathologic Features of Tumors in Mice with Conditional Inactivation of Brca1, p53 and Rb
###end title 40
###begin p 41
###xml 278 287 278 287 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 278 287 278 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g004"><bold>Figure 4A</bold></xref>
###xml 516 525 516 525 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 516 525 516 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g004"><bold>Figure 4B</bold></xref>
###xml 782 791 782 791 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4C</bold>
###xml 782 791 782 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g004"><bold>Figure 4C</bold></xref>
###xml 805 814 805 814 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 805 814 805 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g004"><bold>Figure 4D</bold></xref>
###xml 897 906 897 906 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4E</bold>
###xml 897 906 897 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g004"><bold>Figure 4E</bold></xref>
There was no obvious difference in the pathology of the tumors as related to their genotype. H&E stained sections revealed densely-packed and highly malignant cells with spindle-shape morphology, as well as the presence of anaplastic giant cells in all of the samples examined (Figure 4A). Further immunohistochemical analyses revealed that the tumors were predominantly negative for the epithelial marker cytokeratin (CK) 19, with the exception of some glandular structures present in a small number of the tumors (Figure 4B). These tumors were also probed for the presence of other epithelial markers such as CK8 and pan-cytokeratin and were found to be negative with the exception of the areas noted above. All of the tumors examined were positive for smooth muscle actin (SMA) (Figure 4C) and desmin (Figure 4D), both smooth muscle markers, and were negative for CD34, a hematological marker (Figure 4E). Pathologic review of tumor histology and immunohistochemical data indicates that these tumors are malignant leiomyosarcomas.
###end p 41
###begin title 42
Representative images of tumor histology.
###end title 42
###begin p 43
###xml 130 131 126 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 144 145 140 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 168 169 164 165 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 198 199 194 195 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 215 216 211 212 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
Paraffin sections (5 microm) of the tumors were stained with H&E or specific antibodies to examine histology and gene expression: A) H&E (200X) B) cytokeratin19 (400X) C) smooth muscle actin (200X) D) desmin (100X) E) CD34 (100X). Antigen detection in B-E is by the presence of a brownish-red stain.
###end p 43
###begin p 44
###xml 249 258 249 258 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5A</bold>
###xml 249 258 249 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g005"><bold>Figure 5A</bold></xref>
###xml 394 403 394 403 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 394 403 394 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g005"><bold>Figure 5B</bold></xref>
###xml 490 499 490 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5C</bold>
###xml 490 499 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g005"><bold>Figure 5C</bold></xref>
###xml 632 641 632 641 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5D</bold>
###xml 632 641 632 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g005"><bold>Figure 5D</bold></xref>
###xml 734 743 734 743 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5E</bold>
###xml 734 743 734 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g005"><bold>Figure 5E</bold></xref>
###xml 763 766 763 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 766 775 766 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 777 779 773 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 779 786 775 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 787 790 779 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 790 799 782 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 806 815 794 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 819 828 803 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 834 836 814 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 836 843 816 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 844 849 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 849 858 825 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 859 862 831 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 862 871 834 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 1109 1113 <span type="species:ncbi:10090">mice</span>
The gross pathology along with the H&E sections provided some clues as to the origin of the tumors. In some instances, normal ovary was visible at the edge of a tumor, such that the bursal membrane that surrounds the ovary was flush with the tumor (Figure 5A). In some cases, even when normal ovary was not grossly visible at necropsy, the ovary was found within the H&E sections of the tumor (Figure 5B). In these sections, the tumors also appeared to be connected to the bursal membrane (Figure 5C). Staining of sections of normal ovaries revealed that the bursa, which is an extension of the oviduct, is highly positive for SMA (Figure 5D). Staining also revealed that the inner lining of the bursal membrane is positive for CK19 (Figure 5E). Ovaries from the p53Delta2-10, RbDelta19/p53Delta2-10, Brca1Delta5-13/p53Delta2-10, and RbDelta19/Brca1Delta5-13/p53Delta2-10 mice at early time points (60 and 120 days) were uninformative in terms of potential precursor lesions for these tumors. There were no advanced morphological changes (invaginations or inclusion cysts) noted in ovaries collected from the mice at 60 or 120 days post-AdCre injection (data not shown).
###end p 44
###begin title 45
Tumors appear to be associated with the ovarian bursal membrane.
###end title 45
###begin p 46
###xml 24 25 24 25 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 45 46 45 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 51 52 51 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 192 193 192 193 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 285 286 285 286 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
Gross anatomical image (A) and H&E sections (B and C) showing involvement of ovarian bursal membrane with tumor. T = tumor, b = bursal membrane, Ov = oviduct, O = ovary, and u = uterus (25X). D) SMA staining (reddish-brown stain) of a normal ovary with an intact bursal membrane (25X) E) CK19 staining (reddish-brown stain) of a normal ovary with an intact bursal membrane (400X).
###end p 46
###begin title 47
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
Effect of Concomitant Inactivation of Multiple Tumor Suppressor Genes on Proliferation of MOSE Cells In Vitro
###end title 47
###begin p 48
###xml 155 162 155 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 382 385 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 389 392 389 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 392 401 392 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 510 513 510 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 659 661 659 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 665 667 665 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 667 676 667 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 755 764 755 764 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6A</bold>
###xml 755 764 755 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g006"><bold>Figure 6A</bold></xref>
###xml 777 782 777 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 787 789 787 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 810 812 810 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 812 821 812 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 822 827 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 827 836 827 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 884 889 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 913 922 913 922 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6G</bold>
###xml 913 922 913 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g006"><bold>Figure 6G</bold></xref>
###xml 1018 1026 1018 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb/Brca1</italic>
###xml 1044 1053 1044 1053 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6B</bold>
###xml 1044 1053 1044 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g006"><bold>Figure 6B</bold></xref>
###xml 1061 1064 1061 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1101 1103 1101 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1107 1109 1107 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1109 1118 1109 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1119 1122 1119 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1122 1131 1122 1131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1158 1164 1158 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb/p53</italic>
###xml 1365 1374 1365 1374 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6C</bold>
###xml 1365 1374 1365 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g006"><bold>Figure 6C</bold></xref>
###xml 1439 1441 1439 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1441 1450 1441 1450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1454 1455 1454 1455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sup>
###xml 1451 1455 1451 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>l</sup></italic>
###xml 1455 1463 1455 1463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oxP/loxP</sup>
###xml 1464 1469 1464 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1469 1478 1469 1478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1594 1603 1594 1603 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6D</bold>
###xml 1594 1603 1594 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g006"><bold>Figure 6D</bold></xref>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
The appearance of non-epithelial tumors in the mice limited the investigation of the consequences of disruption of the tumor suppressor genes in OSE cells in vivo. We therefore isolated MOSE cells from mice with conditional expression of these genes and have previously demonstrated that inactivation of Brca1 in MOSE cells resulted in decreased proliferation [36]. Inactivation of p53 in p53loxP/loxP MOSE cells had no effect on proliferation, but proliferation was dramatically increased when both Brca1 and p53 were inactivated [36]. Here we show that, when growth rates were examined 72 hours after exposure to AdGFP or AdCre, conditional inactivation of Rb in RbloxP/loxP MOSE cells had no effect on proliferation over the subsequent 96 hour period (Figure 6A). When both Brca1 and Rb were inactivated in RbloxP/loxP/Brca1loxP/loxP MOSE cells, the proliferation defect seen when Brca1 was inactivated alone (Figure 6G) was eliminated; however there was no significant increase in the rate of proliferation of the Rb/Brca1-deficient cells (Figure 6B). When p53 was inactivated in conjunction with Rb in RbloxP/loxP/p53loxP/loxP MOSE cells, the resulting Rb/p53-deficient cells showed a dramatic increase in proliferation as compared to their control (AdGFP-infected) counterparts, resulting in double the number of cells counted after 72 and 96 hours (P<0.001; Figure 6C). When all three tumor suppressor genes were inactivated in the RbloxP/loxP/p53loxP/loxP/Brca1loxP/loxP MOSE cells, there was a significant increase in their proliferation compared to the AdGFP-infected cells (P<0.001; Figure 6D), resulting in a 2.7-fold increase in cell number after 96 hours.
###end p 48
###begin title 49
MOSE cell proliferation following inactivation of tumor suppressors.
###end title 49
###begin p 50
###xml 122 123 122 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 125 127 125 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 127 136 127 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 201 209 201 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19)</sup>
###xml 224 226 220 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 242 244 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 244 253 240 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 256 257 252 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 259 261 255 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 261 270 257 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 271 276 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 276 285 272 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 320 327 316 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 328 333 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 333 342 325 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 358 360 346 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 365 370 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 386 388 374 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 388 397 376 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 398 403 386 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 403 412 391 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 415 416 403 404 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 418 420 406 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 420 429 408 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 430 433 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 433 442 421 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 469 471 457 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 471 478 459 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 479 482 463 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 482 491 466 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 507 509 487 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 514 517 494 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 528 530 508 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 530 539 510 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 540 543 520 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 543 552 523 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 555 556 535 536 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 558 560 538 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 560 569 540 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 570 573 550 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 573 582 553 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 583 588 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 588 597 568 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 624 626 604 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 626 633 606 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 634 637 610 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 637 646 613 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 647 652 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 652 661 624 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 673 675 641 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 675 684 643 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 685 688 653 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 688 697 656 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 698 703 666 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 703 712 671 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 715 721 683 689 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E&#8211;F, H</bold>
###xml 803 804 771 772 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 806 809 774 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 809 818 777 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 823 826 791 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 826 835 794 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 842 843 806 807 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 845 847 809 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 847 856 811 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 863 870 827 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 877 878 837 838 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 880 885 840 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 885 894 845 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 899 904 859 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 904 913 864 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 979 980 935 936 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 982 987 938 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 987 996 943 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1001 1006 957 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1006 1015 962 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 1076 1077 1028 1029 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 1122 1127 1074 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1127 1136 1079 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1173 1181 1125 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1204 1209 1156 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1209 1218 1161 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 1230 1235 1178 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1235 1244 1183 1192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
Number of viable MOSE cells evaluated 72 hours (A-D, G) or several passages (E-F, H) after infection with AdCre or AdGFP. A) RbloxP/loxP MOSE cells evaluated 72 hours following infection with AdCre (RbDelta19) to inactivate Rb or with AdGFP (RbloxP/loxP). B) RbloxP/loxP/Brca1loxP/loxP MOSE cells infected with AdCre (RbDelta19/Brca1Delta5-13) to inactivate Rb and Brca1 or with AdGFP (RbloxP/loxP/Brca1loxP/loxP). C) RbloxP/loxP/p53loxP/loxP MOSE infected with AdCre (RbDelta19/p53Delta2-10) to inactivate Rb and p53 or AdGFP (RbloxP/loxP/p53loxP/loxP). D) RbloxP/loxP/p53loxP/loxP/Brca1loxP/loxP MOSE infected with AdCre (RbDelta19/p53Delta2-10/Brca1Delta5-13) or AdGFP (RbloxP/loxP/p53loxP/loxP/Brca1loxP/loxP). E-F, H) Proliferation of MOSE cells 4-9 passages following infection of AdCre or AdGFP. E) p53loxP/loxP vs. p53Delta2-10 MOSE. F) RbloxP/loxP vs. RbDelta19 MOSE. G) Brca1loxP/loxP vs. Brca1Delta5-13 MOSE evaluated 72 hours following infection with AdCre or AdGFP. H) Brca1loxP/loxP vs. Brca1Delta5-13 MOSE, 4-9 passages following infection with AdCre or AdGFP. I) PCR of genomic DNA collected from cultured Brca1loxP/loxP OSE cells 1 or 6 passages following in vitro infection with AdCre (Brca1Delta5-13) or AdGFP (Brca1loxP/loxP). Error bars represent the SEM of data obtained from three experiments performed in triplicate. *, ** and *** indicate a significant difference where P<0.05, P<0.01 and P<0.001, respectively.
###end p 50
###begin p 51
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 34 43 34 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 116 119 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 277 286 273 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6E</bold>
###xml 277 286 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g006"><bold>Figure 6E</bold></xref>
###xml 317 319 313 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 319 326 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 429 438 421 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6F</bold>
###xml 429 438 421 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g006"><bold>Figure 6F</bold></xref>
###xml 454 459 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 555 560 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 562 571 554 563 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6G</bold>
###xml 562 571 554 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g006"><bold>Figure 6G</bold></xref>
###xml 667 676 659 668 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6H</bold>
###xml 667 676 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g006"><bold>Figure 6H</bold></xref>
###xml 824 833 816 825 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6I</bold>
###xml 824 833 816 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g006"><bold>Figure 6I</bold></xref>
###xml 924 929 916 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
When the proliferation rate of p53Delta2-10 MOSE cells was examined several passages following AdCre infection, the p53-deficient MOSE had developed a significantly increased rate of proliferation compared to AdGFP-infected cells cultured for the same length of time (P<0.001, Figure 6E). After several passages, the RbDelta19 MOSE cells also had a significantly increased rate of proliferation, detectable as early as 48 hours (Figure 6F). In contrast, Brca1-deficient MOSE, which showed a reduced rate of proliferation immediately after inactivation of Brca1 (Figure 6G), failed to show any difference from their AdGFP-infected counterparts after several passages (Figure 6H). While recombination at the loxP sites could still be detected in the AdCre-infected cells at this stage, non-recombined DNA was now predominant (Figure 6I), suggesting that the MOSE cells without recombination were outgrowing the slower growing Brca1-deficient cells.
###end p 51
###begin title 52
###xml 100 108 100 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
Effect of Inactivation of Multiple Tumor Suppressor Genes on Sensitivity to Cisplatin in MOSE Cells In Vitro
###end title 52
###begin p 53
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 289 298 289 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 299 302 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 302 311 298 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 316 321 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 321 330 313 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 331 334 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 334 343 326 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 365 369 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 393 395 385 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 395 402 387 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 485 487 473 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 487 496 475 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 609 618 593 602 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7A</bold>
###xml 609 618 593 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g007"><bold>Figure 7A</bold></xref>
###xml 640 642 624 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 647 652 631 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 661 663 645 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 668 671 652 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 857 868 841 852 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7B,C</bold>
###xml 857 868 841 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g007"><bold>Figure 7B,C</bold></xref>
###xml 943 945 927 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 945 954 929 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 955 958 939 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 958 967 942 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 968 973 952 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 973 982 957 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1144 1153 1124 1133 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7D</bold>
###xml 1144 1153 1124 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008534-g007"><bold>Figure 7D</bold></xref>
Inactivation of Brca1 or p53 alone in MOSE cells in vitro renders them significantly more sensitive to treatment with the chemotherapeutic agent cisplatin; however, when both Brca1 and p53 are conditionally inactivated, there is no significant difference between the sensitivities of Brca1Delta5-13/p53Delta2-10 and Brca1loxP/loxP/p53loxP/loxP cells after 48 hours [36]. Here we show that the RbDelta19 MOSE cells were also significantly more sensitive to cisplatin treatment than the RbloxP/loxP cells (33.28%+/-0.95% versus 46.85%+/-2.42%, P<0.01, viable cells expressed as a percentage of untreated cells, Figure 7A). However, when both Rb and Brca1 or both Rb and p53 were inactivated in MOSE cells, there was no difference in the proportion of cells remaining viable after 48 hours of treatment with cisplatin, relative to the AdGFP-infected controls (Figure 7B,C). The concomitant inactivation of all three tumor suppressor genes in the RbloxP/loxP/p53loxP/loxP/Brca1loxP/loxP cells had no impact on the sensitivity of these cells to treatment with 5 microM of cisplatin for 48 hours compared to the corresponding control-infected cells (Figure 7D).
###end p 53
###begin title 54
Treatment of MOSE cells with cisplatin following inactivation of multiple tumor suppressors.
###end title 54
###begin p 55
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 60 62 60 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 185 186 181 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 188 190 184 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 190 199 186 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 239 241 235 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 241 248 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 260 262 252 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 262 271 254 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 274 275 266 267 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 277 279 269 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 279 288 271 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 289 294 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 294 303 286 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 343 345 335 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 345 352 337 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 353 358 341 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 358 367 346 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 379 381 363 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 381 390 365 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 391 396 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 396 405 380 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 408 409 392 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 411 413 395 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 413 422 397 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 423 426 407 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 426 435 410 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 475 477 459 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 477 484 461 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 485 488 465 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 488 497 468 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 509 511 485 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 511 520 487 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 521 524 497 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 524 533 500 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 540 541 516 517 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 543 545 519 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 545 554 521 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 555 558 531 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 558 567 534 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 568 573 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 573 582 549 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 622 624 598 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 624 631 600 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 632 635 604 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 635 644 607 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 645 650 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 650 659 618 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5-13</sup>
###xml 671 673 635 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 673 682 637 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 683 686 647 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 686 695 650 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 696 701 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 701 710 665 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
MOSE cells with specific inactivation of Brca1, p53, and/or Rb in various combinations were tested for their sensitivity to cisplatin by treatment with 5 microM cisplatin for 48 hours. A) RbloxP/loxP MOSE cells infected with either AdCre (RbDelta19) or AdGFP (RbloxP/loxP); B) RbloxP/loxP/Brca1loxP/loxP MOSE cells infected with either AdCre (RbDelta19/Brca1Delta5-13) or AdGFP (RbloxP/loxP/Brca1loxP/loxP); C) RbloxP/loxP/p53loxP/loxP MOSE cells infected with either AdCre (RbDelta19/p53Delta2-10) or AdGFP (RbloxP/loxP/p53loxP/loxP); and D) RbloxP/loxP/p53loxP/loxP/Brca1loxP/loxP MOSE cells infected with either AdCre (RbDelta19/p53Delta2-10/Brca1Delta5-13) or AdGFP (RbloxP/loxP/p53loxP/loxP/Brca1loxP/loxP). Values are the number of adherent cells presented as a proportion of similar cells exposed to the vehicle control (untreated cells). Error bars represent the SEM of three experiments performed in triplicate. **indicates a significant difference where P<0.01.
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 316 319 316 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 363 368 363 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Ramus1">[25]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Zweemer1">[26]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Cressman1">[27]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Xu1">[31]</xref>
###xml 548 553 548 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 641 644 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 652 654 652 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 741 744 741 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 849 854 849 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 352 357 <span type="species:ncbi:9606">women</span>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
Our previous work showed that when Brca1 was inactivated in vivo via intrabursal injection of AdCre, no tumorigenesis occurred when the animals were followed past one year post-injection, despite the development of significantly more premalignant changes in the OSE of these ovaries [36]. The frequent occurrence of p53 mutations in ovarian cancers in women with BRCA1 mutations [25], [26] and the apparent cooperation of Brca1 and p53 in mouse models of mammary cancers [27]-[31] led us to perform experiments in which conditional inactivation of Brca1 was targeted to the OSE, along with the conditional inactivation the tumor suppressors p53 and/or Rb. Our results show that invasive tumors developed in all mice that had inactivation of p53 targeted to the OSE and that tumor development was accelerated in mice with concomitant inactivation of Brca1.
###end p 57
###begin p 58
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 43 47 43 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-FleskenNikitin1">[35]</xref>
###xml 77 79 77 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 79 86 79 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 87 90 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 90 99 86 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 186 189 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 193 195 185 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 250 252 242 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 252 259 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;19</sup>
###xml 260 263 248 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 263 272 251 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;2-10</sup>
###xml 399 402 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 507 511 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Sood1">[40]</xref>
###xml 641 645 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-deVos1">[41]</xref>
###xml 646 650 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Leiser1">[43]</xref>
###xml 695 698 679 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 753 757 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Donehower1">[44]</xref>
###xml 759 763 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Jacks1">[45]</xref>
###xml 941 945 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-FleskenNikitin1">[35]</xref>
###xml 947 951 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 953 957 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Dinulescu1">[46]</xref>
###xml 1324 1327 1308 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Auersperg1">[1]</xref>
###xml 1373 1376 1357 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1499 1503 1483 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-FleskenNikitin1">[35]</xref>
###xml 1505 1509 1489 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 1511 1515 1495 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Dinulescu1">[46]</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 501 506 <span type="species:ncbi:9606">women</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
Based on the work of Flesken-Nikitin et al.[35], it was anticipated that the RbDelta19/p53Delta2-10 mice would develop adenocarcinomas with little to no tumor formation seen when either p53 or Rb was inactivated alone. In contrast to that study, the RbDelta19/p53Delta2-10 mice in this study died of tumors that were classified as malignant leiomyosarcomas. Furthermore, conditional inactivation of p53 alone led to the development of leiomyosarcomas in 100% of the mice. Ovarian sarcomas are rare in women [40], although aberrations in both the p53 and Rb pathways have been implicated in the development and progression of leiomyosarcomas [41]-[43], and mice that are null or heterozygous for p53 are highly prone to developing lymphomas and sarcomas [44], [45]. Several groups have shown the capacity for OSE to develop into epithelial tumors using the method of intrabursal injection of AdCre for the activation or inactivation of genes [35], [36], [46], indicating that these cells are capable of transformation to epithelial cancers. The reasons for the prevalence of leiomyosarcomas are therefore unclear, but there are several possible factors that should be considered. First, the OSE is a poorly differentiated epithelium that is known to undergo epithelial-mesenchymal transition during the peri-ovulatory period [1], and it is possible that the inactivation of p53 facilitated transformation more effectively in these mesenchymal cells. Second, although evidence from our lab and others [35], [36], [46] indicate that intrabursal delivery of adenoviruses results in infection of primarily surface epithelial cells, it may be possible that some underlying stromal cells are also infected and are more readily transformed than the epithelial cells.
###end p 58
###begin p 59
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-LeCouter1">[47]</xref>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Woodworth1">[49]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-FleskenNikitin1">[35]</xref>
###xml 1352 1356 1352 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Laviolette1">[50]</xref>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 190 195 <span type="species:ncbi:10090">mouse</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
A third reason for the occurrence of leiomyosarcomas in this study may be differences in the strain of mouse used. Genetic modifiers due to strain differences can influence the phenotype in mouse models of disease [47]-[49], so it is possible that strain differences may account for the discrepancies in both tumor incidence and histology. The animals utilized in the Flesken-Nikitin study [35] were backcrossed to the FVB/n strain, whereas the animals in this study were maintained on the FVB/n;129sv mixed strain background. Finally, it is possible that, in the strain used in this study, the smooth muscle cells of the bursal membrane, which would also be in contact with the adenoviral Cre recombinase, are more sensitive to the consequences of these recombination events than the OSE. The bursal membrane is largely composed of smooth muscle cells, much like the uterine and oviductal myometrium with which it is contiguous. Since the tumors that developed in these mice were generally found to be continuous with the bursal membrane, it may be that the tumors are arising from this tissue rather than the ovarian surface epithelium. We have recently found that Cre-mediated recombination can occur in cells in the bursal membrane and that cells carrying the recombined gene can still be found at least 65 days after intrabursal delivery of AdCre [50].
###end p 59
###begin p 60
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 174 177 174 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 182 189 182 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53/pRb</italic>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Lynch1">[51]</xref>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 602 607 602 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 668 672 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Xing1">[52]</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Yu1">[19]</xref>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 283 288 <span type="species:ncbi:9606">women</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
Despite this unanticipated phenotype, Brca1-deficiency in these tumors influenced the survival time of the mice, causing a significant reduction in the length of survival of p53 and p53/pRb-deficient mice, compared to the mice without Brca1 deficiency. Breast and ovarian cancers in women with BRCA1 mutations arise at an earlier age than sporadic cancers [51], so it was interesting to observe that, despite the difference in histologic phenotype, inactivation of Brca1 in mice resulted in tumors that developed more quickly. This action is in agreement with a recent report describing the ability of BRCA1 deficiency to accelerate uterine leiomyosarcoma development [52]. The mechanism of this acceleration in tumor initiation and/or progression is unknown, although loss of Brca1 function is associated with genomic instability [19].
###end p 60
###begin p 61
###xml 42 50 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-ClarkKnowles1">[36]</xref>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Cressman1">[27]</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Xu1">[31]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Hakem1">[53]</xref>
###xml 479 482 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 487 489 487 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-FleskenNikitin1">[35]</xref>
###xml 710 715 710 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 717 720 717 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 725 727 725 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
When MOSE cell proliferation was examined in vitro, the concomitant inactivation of p53 rescued the growth suppression that was seen with inactivation of Brca1 alone [36] and led to a substantially increased growth rate as compared to control cells. Loss of p53 function has been demonstrated to partially rescue the embryonic lethality of Brca1 knockout mice and appears to play a critical role in mammary tumorigenesis in mice [27]-[31], [53]. Concomitant inactivation of both p53 and Rb also resulted in a significant increase in proliferation in MOSE cells, an observation in agreement with results of similar studies reported previously [35]. Conditional inactivation of all three tumor suppressor genes, Brca1, p53 and Rb, simultaneously in MOSE cells resulted in a dramatic increase in proliferation with significant increases in cell number with time over any of the other genotypic combinations. This increased rate of proliferation may explain the acceleration in tumor progression in cells lacking all three genes.
###end p 61
###begin p 62
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 23 25 23 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 517 523 517 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53/Rb</italic>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Heller1">[54]</xref>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
Inactivation of p53 or Rb alone in MOSE cells had no immediate effect on proliferation, but after at least four passages, the growth characteristics became notably different, showing increased rates of proliferation relative to controls. These results suggest that, with prolonged culture, these cells may spontaneously acquire further genetic abnormalities that result in uncontrolled proliferation. The lack of any obvious morphological alterations in the OSE at 60 or 120 days after intrabursal AdCre injection in p53/Rb-deficient mice supports the hypothesis that tumor initiation requires additional genetic changes. The long latency in tumor development could be a result of the relatively low proliferative index of the OSE [54].
###end p 62
###begin p 63
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Lanzi1">[55]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Perego1">[56]</xref>
###xml 496 499 496 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Aunoble1">[14]</xref>
###xml 656 660 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Brugarolas1">[57]</xref>
###xml 661 665 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008534-Xu2">[59]</xref>
###xml 681 686 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 733 736 733 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 740 742 740 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 840 843 840 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 847 849 847 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
The increased sensitivity of MOSE to cisplatin treatment observed when only one tumor suppressor gene is inactivated appears to be lost when two or more are inactivated simultaneously. Cisplatin-resistant ovarian and cervical carcinoma cells have been shown to harbour multiple genetic changes, particularly affecting pathways leading to apoptosis that render the cells aberrantly tolerant of accumulated DNA damage [55], [56]. In this regard, familial ovarian cancers have a higher frequency of p53 mutations than sporadic cancers [14], and it has been suggested that loss of p53 function is required for a cell to tolerate the loss of the Brca1 function [57]-[59]. Thus, loss of Brca1 may result in compensation in the cell by the p53 or Rb pathways, resulting in an increased apoptotic response to cisplatin. The concomitant loss of the p53 or Rb expression may enable the cells to better tolerate cellular stresses, including exposure to cisplatin.
###end p 63
###begin p 64
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
These results show similarities to mouse models of mammary tumorigenesis and uterine leiomyosarcomas in that Brca1 inactivation can accelerate the initiation and/or progression of p53-mediated tumors. Brca1 status, in combination with that of other tumor suppressor pathways, influence sensitivity of OSE cells to chemotherapeutic agents. The combination of tumor suppressors inactivated in this study failed to yield epithelial cancers, indicating that further analyses are needed to determine the mechanisms by which BRCA1 mutations cause transformation of the ovarian epithelium.
###end p 64
###begin p 65
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 78 87 78 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 136 139 136 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 139 148 139 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 216 218 216 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 218 227 218 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
We are grateful to Dr. Anton Berns and Dr. Jos Jonkers for providing the Brca1loxP/loxP mice ahead of publication and for providing the p53loxP/loxP mice. We would also like to thank Dr. Ruth Slack for providing the RbloxP/loxP mice, Kerri Courville and Colleen Crane for their technical assistance, and Dr. Ken Garson for his critical review of the manuscript.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
The biology of ovarian cancer.
###end article-title 67
###begin article-title 68
High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy.
###end article-title 68
###begin article-title 69
Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.
###end article-title 69
###begin article-title 70
New insights into the pathogenesis of serous ovarian cancer and its clinical impact.
###end article-title 70
###begin article-title 71
Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?
###end article-title 71
###begin article-title 72
Ovarian surface epithelium: biology, endocrinology, and pathology.
###end article-title 72
###begin article-title 73
###xml 25 30 <span type="species:ncbi:9606">human</span>
E-cadherin expression in human epithelial ovarian cancer and normal ovary.
###end article-title 73
###begin article-title 74
Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.
###end article-title 74
###begin article-title 75
Prophylactic oophorectomy: a morphologic and immunohistochemical study.
###end article-title 75
###begin article-title 76
###xml 77 82 <span type="species:ncbi:9606">women</span>
Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer.
###end article-title 76
###begin article-title 77
Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.
###end article-title 77
###begin article-title 78
Frequency of germline and somatic BRCA1 mutations in ovarian cancer.
###end article-title 78
###begin article-title 79
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
###end article-title 79
###begin article-title 80
Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).
###end article-title 80
###begin article-title 81
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
###end article-title 81
###begin article-title 82
Frequency of BRCA1 dysfunction in ovarian cancer.
###end article-title 82
###begin article-title 83
Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers.
###end article-title 83
###begin article-title 84
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
###end article-title 84
###begin article-title 85
Caretaker Brca1: keeping the genome in the straight and narrow.
###end article-title 85
###begin article-title 86
BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
###end article-title 86
###begin article-title 87
Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage.
###end article-title 87
###begin article-title 88
###xml 49 54 <span type="species:ncbi:9606">human</span>
A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells.
###end article-title 88
###begin article-title 89
BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
###end article-title 89
###begin article-title 90
Induction of apoptosis by the tumor suppressor protein BRCA1.
###end article-title 90
###begin article-title 91
Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.
###end article-title 91
###begin article-title 92
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.
###end article-title 92
###begin article-title 93
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Mammary tumor formation in p53- and BRCA1-deficient mice.
###end article-title 93
###begin article-title 94
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice.
###end article-title 94
###begin article-title 95
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.
###end article-title 95
###begin article-title 96
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Mammary tumor formation in p53- and BRCA1-deficient mice.
###end article-title 96
###begin article-title 97
Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
###end article-title 97
###begin article-title 98
BRCA1-associated growth arrest is RB-dependent.
###end article-title 98
###begin article-title 99
Regulation of BRCA1 expression by the Rb-E2F pathway.
###end article-title 99
###begin article-title 100
Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding.
###end article-title 100
###begin article-title 101
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.
###end article-title 101
###begin article-title 102
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.
###end article-title 102
###begin article-title 103
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
###end article-title 103
###begin article-title 104
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse.
###end article-title 104
###begin article-title 105
###xml 16 22 <span type="species:ncbi:10090">murine</span>
Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS.
###end article-title 105
###begin article-title 106
Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction.
###end article-title 106
###begin article-title 107
p53 alterations in uterine leiomyosarcomas versus leiomyomas.
###end article-title 107
###begin article-title 108
Tumor suppressor genes and related molecules in leiomyosarcoma.
###end article-title 108
###begin article-title 109
Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma.
###end article-title 109
###begin article-title 110
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
###end article-title 110
###begin article-title 111
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Tumor spectrum analysis in p53-mutant mice.
###end article-title 111
###begin article-title 112
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.
###end article-title 112
###begin article-title 113
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene.
###end article-title 113
###begin article-title 114
###xml 0 4 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
MMTV-trBrca1 mice display strain-dependent abnormalities in vaginal development.
###end article-title 114
###begin article-title 115
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte.
###end article-title 115
###begin article-title 116
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
17beta-estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer.
###end article-title 116
###begin article-title 117
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.
###end article-title 117
###begin article-title 118
A role for BRCA1 in uterine leiomyosarcoma.
###end article-title 118
###begin article-title 119
Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.
###end article-title 119
###begin article-title 120
Lack of proliferative activity of surface epithelial inclusion cysts of the ovary.
###end article-title 120
###begin article-title 121
Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance.
###end article-title 121
###begin article-title 122
Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol.
###end article-title 122
###begin article-title 123
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair.
###end article-title 123
###begin article-title 124
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.
###end article-title 124
###begin article-title 125
Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
###end article-title 125
###begin p 126
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 126
###begin p 127
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 139 142 <span type="species:ncbi:11128?0.8931297709923665">BCV</span>
Funding: This research was supported by funds from the National Cancer Institute of Canada and the Canadian Institutes of Health Research (BCV) and by Ontario Graduate Scholarships and an Ontario Graduate Scholarship in Science and Technology (KVC-K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 127

